MHK
55
12
WMT
63
-3
GRMN
52
2
PLD
56
5
BK
74
2
SIG
60
2
PDCO
58
3
MAR
53
3
PVH
54
2
AAPL
46
6
DAL
66
2
DOV
69
6
RRC
52
2
AES
49
-2
WDC
52
3
HD
54
4
EOG
50
3
NVDA
55
4
PSA
63
-3
ETR
66
-2
MHK
55
12
WMT
63
-3
GRMN
52
2
PLD
56
5
BK
74
2
SIG
60
2
PDCO
58
3
MAR
53
3
PVH
54
2
AAPL
46
6
DAL
66
2
DOV
69
6
RRC
52
2
AES
49
-2
WDC
52
3
HD
54
4
EOG
50
3
NVDA
55
4
PSA
63
-3
ETR
66
-2
Financhill
Back

Context Therapeutics Stock Predictions

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
66

CNTX
Context Therapeutics

Last Price:
2.22
Seasonality Move:
-29.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market

Context Therapeutics Stock Forecast

  • Is Context Therapeutics Stock Undervalued?
    The current Context Therapeutics [CNTX] share price is $2.22. The Score for CNTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • CNTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Context Therapeutics Stock Go Up Next Year?

Data Unavailable

Context Therapeutics Stock Rating

Data Unavailable

Context Therapeutics Stock Price History

Is CNTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
contexttherapeutics.com

52-Week Data

52-Week High:
2.75
52-Week Low:
0.77

Prediction Charts

Market Cap:
166.5M
Price in USD:
2.22
Volume:
38.14K
Beta:
2.28

Technical Analysis

SMA50:
2.30
SMA100:
2.09
SMA200:
1.62
52-Wk Change:
136.17%

Stock Predictions

  • Is Context Therapeutics stock public?
    Yes, Context Therapeutics is a publicly traded company.
  • What is the Context Therapeutics stock quote today?
    The Context Therapeutics stock price is 2.22 USD today.
  • How to buy Context Therapeutics stock online?
    You can buy Context Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 2.47 2.46 2.49 2.43
Sep-3 2.46 2.44 2.50 2.42
Sep-4 2.45 2.43 2.55 2.34
Sep-5 2.40 2.28 2.44 2.28
Sep-6 2.30 2.29 2.38 2.21
Sep-9 2.31 2.14 2.31 2.10
Sep-10 2.12 2.13 2.19 2.09
Sep-11 2.14 2.14 2.18 2.05
Sep-12 2.11 2.14 2.25 2.11
Sep-13 2.21 2.09 2.23 2.03
Sep-16 2.04 2.08 2.14 2.03
Sep-17 2.05 2.08 2.10 2.04
Sep-18 2.10 1.96 2.12 1.94
Sep-19 1.96 2.22 2.23 1.96

Context Therapeutics Earnings

Data Unavailable

Context Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.14 per share, and a decrease next year of $0.02 per share.

* Context Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.